A simple repeat was found to be inserted into exon 9 of the c-myb gene in three out of 20 bovine T lymphomas. The repeat was composed of multiple copies of a 12-nucleotide motif and had no signi®cant homology to the sequences reported so far. Tumor cells containing the repeat expressed two kinds of c-myb mRNA: (1) are that included the repetitive sequence in exon 9, and (2) are that lacked the whole sequence of exon 9. Transfection of an expression vector containing exon and intron sequences and reverse transcriptase-polymerase chain reaction (RT ± PCR) analysis of the mRNA demonstrated that the insertion of the repeat enhanced exon skipping of the transfected minigene. These observations imply that the insertion of the repeat may enhance exon skipping of the c-myb pre-mRNA. Although the transcription-activating activity by the c-Myb with the repeat was low, that by the c-Myb without exon 9 was three-to eightfold higher than the wild-type c-Myb. These data suggest that insertion of the 12-nucleotide repeat in codon 359 may result in c-Myb proteins having high-and low-transcription-activating activity.
Introduction
The c-myb is a proto-oncogene encoding a DNAbinding transcriptional activator that seems to regulate genes critical for hematopoietic cell growth and development. The c-myb is the cellular homologue of the v-myb oncogene originally found in the avian myeloblastosis virus, AMV and E26 retroviruses (Klempnauer et al., 1982; Radke et al., 1982) . The vMybs encoded by AMV and E26 are amino (N)-and carboxyl (C)-terminally truncated versions of c-Myb. These v-Mybs have oncogenic transforming activity and transcription-activating activity.
Both v-Myb and c-Myb are nuclear proteins and bind to the DNA sequence (T/C)AAC(G/C)G (Biedenkapp et al., 1988; Howe and Watson, 1991) . Functional binding sites for c-Myb have been found in several potential target genes activated by c-Myb, including the promyelocyte-speci®c mim-1 gene (Ness et al., 1989) , the CD4 glycoprotein gene (Siu et al., 1992) , the CD34 glycoprotein gene (Melotti et al., 1994) , the cdc2 gene (Ku et al., 1993) , the PR264/SC35 splicing factor gene (Sureau et al., 1992) , the T cell receptor d genes (Wang et al., 1993; HernaÂ ndezMunain and Krangel, 1994) , the c-myc protooncogene (Evans et al., 1990; Zobel et al., 1991) , and c-myb itself (Nicolaides et al., 1991) . The c-Myb comprises three functional domains responsible for DNA binding, transcriptional activation and negative regulation (Sakura et al., 1989) . The DNA binding domain consists of three imperfect repeats (R1, R2 and R3 in c-Myb) of 50 ± 52 amino acids (Peters et al., 1987; Klempnauer and Sippel, 1987; Weston and Bishop, 1989; Howe et al., 1990; Ibanez and Lipsick, 1990; Kalkbrenner et al., 1990; Nakagoshi et al., 1990; Gabrielsen et al., 1991; Ogata et al., 1994) . A hydrophilic region in the center of the c-Myb molecule seems to act as a transcriptional activator (Sakura et al., 1989; Weston and Bishop, 1989; Ibanez and Lipsick, 1990; Lane et al., 1990) . The C-terminus of c-Myb is thought to contain a negative regulatory domain (Sakura et al., 1989; Kalkbrenner et al., 1990; Kanei-Ishii et al., 1992) . A heptad leucine repeat (leucine zipper) located between amino acid residues 373 to 407 in the negative regulatory domain is thought to allow the binding of an associated inhibitory factor Favier and Gonda, 1994; Ramsay et al., 1995) . Removal of the negative regulatory domain is responsible for the oncogenic activation of C-terminal truncated forms of c-Myb (Hu et al., 1991; Gonda et al., 1989; Grasser et al., 1991) . However, the boundaries of the transcriptional activator domain and negative regulatory domain are not well-de®ned and appear to depend on the cell line and reporter constructs used (Kalkbrenner et al., 1990; Kanei-Ishii et al., 1992; Nakagoshi et al, 1992; Ishiguro et al., 1994) .
The role of c-myb in cellular dierentiation may be regulated in part by alternative splicing of its mRNA. Alternatively spliced c-myb mRNA have been detected in some hematopoietic tissues and cell lines of human, murine and avian (Shen-Ong, 1987; Westin et al., 1990; Weber et al., 1990; Schuur et al., 1993) . The alternatively spliced exon conserved in mammals and birds lies adjacent to the leucine zipper region located in exon 9. In other cases, viral integration in the c-myb locus seems to generate splicing errors and results in excessive activity of the protein (Weinstein et al., 1986; Rosson et al., 1987; Mukhopadhyaya and Wol, 1992; Bies et al., 1995) . For example, Abelson leukemia virus-induced plasmacytoid lymphosarcomas have added intronic sequences between exon 9 and 10 as a result of the integration of the Moloney murine leukemia virus at a point immediately preceding the ®rst exon of c-myb (Rosson et al., 1987) .
In the bovine T lymphoma cell line BTL-PC3, c-myb mRNA lacking exon 9 was reported by Ishiguro et al. (1994) . The mRNA encoded the 65 kilodaltons (kDa) c-Myb protein containing internal, in-frame deletion of 85 amino acids, including the leucine zipper. The cMyb with the deletion was demonstrated to have threeto sevenfold higher transcription-activating activity than full-length c-Myb. In addition, genomic DNA fragments of c-myb with aberrant mobility have been observed in BTL-PC3 cells by Southern blot analysis. Since c-myb mRNA lacking exon 9 and the aberration in genomic c-myb have not been observed in thymus or other hematopoietic tissues, we investigated what alteration in the genomic c-myb gene was involved in the generation of the deleted form of c-myb mRNA.
We describe here how insertion mutations were found in c-myb gene exon 9 of bovine T lymphomas which expressed c-myb mRNA lacking exon 9. The inserted sequence was composed of 4 to 22 copies of a 12-nucleotide motif and did not show a signi®cant homology to known sequences such as long terminal repeats of retroviruses. Transfection of minigene containing exons and intron sequences of c-myb as well as RT ± PCR analysis of the mRNA demonstrated that the insertion of the repeat in exon 9 enhanced the splicing-out of exon 9. The inserted and deleted forms of c-Myb found in T-lymphomas were examined with regard to the transcription-activating activity.
Results

Bovine T lymphoma c-myb with an insertion mutation
In a previous study , we detected an alteration in mobility of genomic c-myb DNA fragments from the T-lymphoma cell line BTL ± PC3 by Southern blot analysis. To ascertain the genomic alteration, DNA from BTL ± PC3, normal leukocytes and another T lymphoma cell line, Pr2181, were digested with restriction enzymes and analysed by Southern blotting using a fragment of the bovine c-myb gene corresponding to the human exon 9 as a probe. Here, we refer to this fragment as exon 9. HinfIdigested DNA from normal leukocytes and Pr2181 cells contained only a 600 bp fragment, as we had expected ( Figure 1a, lanes 1 and 2) . In addition to the 600 bp fragment, a 800 bp fragment was found in the BTL ± PC3 cells ( Figure 1a, lane 3) . The strength of each signal was almost the same, indicating that the c-myb gene of BTL ± PC3 cells was heterogeneous. Similarly, a Southern blot of the AluI-digested DNA showed that normal leukocytes and Pr2181 cells contained only a 400 bp fragment, whereas BTL ± PC3 cells contained an additional 600 bp fragment. The dierence in length of approximately 200 bp of these additional fragments of BTL ± PC3 cells, as compared with fragments detected from normal leukocytes and Pr2181 cells, shows that these fragments had an insertion of about 200 bp.
A 12-nucleotide repeat insertion
To investigate the alteration of the genomic structure, genomic DNA from Pr2181 cells and BTL26 cells, a clone of BTL ± PC3, were digested with EcoRI and cloned into lZAPII. Probed with the c-myb exon 9 sequence, seven lZAPII clones carrying the 3.5 kb EcoRI fragment were obtained from BTL26 cells. Sequence analysis showed that these fragments contained DNA sequences from exon 7 to exon 9 and an insertion in codon 359, a middle position of exon 9 (Figure 2 ). Inserted sequences in two of the seven clones were 213 bp long and comprised 17 copies of a tandem 12-nucleotide motif (TGATCTGCCCGT) and a 9-nucleotide interruption (TCTGGGCGT). Two other clones had 11 and 22 copies of the motif with the 9-nucleotide interruption. One of the remaining clones was composed of ®ve copies, while the other two clones showed eight copies of the 12-nucleotide motif without interruption. Data base searches of DNA and protein have failed to show any meaningful homologies with previously characterized genes such as retroviruses. Comparison of the cloned sequences between the wild-type allele of Pr2181 and the mutated allele of BTL26 showed that there was no alteration, except that the repetitive sequence was inserted in codon 359 in BTL26 cells. To elucidate the entire structure of intron 9, fragments of about 3.0 kb were ampli®ed from genomic DNA of Pr2181 and BTL26 by long and accurate-polymerase chain reaction (LA ± PCR) using primers myb14 and myb27. Sequence analysis revealed that intron 9 of BTL26 had no alteration compared with that of Pr2181. Besides, introns 8 (1304 bp) and 9 (2804 bp) had the consensus sequences for splicing junction (5'GT-AG3') at the exon ± intron boundaries.
To ascertain if the repetitive sequence is associated with bovine T lymphoma, we surveyed the presence of repetitive sequences in DNA from 35 clinical tumors and 28 normal tissues. Among 18 sporadic bovine T lymphoma samples screened for the c-myb mutation, two samples, Pr2410 and Pr1818, had a detectable shift of the band on either the Southern blot or the PCR or of both (Figures 1 and 3 ). There were no dierences between normal leukocytes and other tumors including 12 samples of sporadic bovine B lymphomas, ®ve samples of enzootic bovine leukemias, two samples of kidney carcinomas, and one sample of an adenoma, as well as 28 samples of normal tissues of cattle which did not have any tumors. Sequence analysis of the PCR products demonstrate that the insertion of Pr2410 tumor tissue comprised 16 copies of the same 12-nucleotide motif with 9-nucleotide direct repeats (TGGGCCCGT) at both ends of the 12-nucleotide repeat ( Figure 2B ). The repeats were not detected in the adrenal gland of the Pr2410 (Figure 3 ), indicating that insertion of the repeat occurred in somatic cells of Pr2410. The insertion of Pr1818 comprised 18 copies of the same 12-nucleotide motif and the 9-nucleotide interruption (TCTGGGCGT) ( Figure 2B ). Interestingly, in these cases two nucleotides (CG) at codon 359 were substituted for TT.
To test if the 12-nucleotide repeat is located at other loci of the genome, the membrane used in Figure 1a was reprobed with the 12-nucleotide repeat fragment ( Figure 1b ). Although no fragment was detected from DNA of normal leukocytes and the Pr2181 cell line, the fragments with the 800 bp (digested with HinfI) and the 600 bp (digested with AluI) corresponding to the fragments of c-myb with the 200 bp insertion were detected in DNA of BTL ± PC3 cells and Pr2410 tumor tissue. This indicated that the repeat was speci®cally inserted into the c-myb gene, but not into other loci.
Expression of the 12-nucleotide repeat
To determine if the c-myb gene containing the 12-nucleotide repeat was transcribed, total RNA from Pr2181 cells and BTL ± PC3 cells were analysed by Wild-type of c-myb gene yielded fragments with 267 bp (myb20 ± 17) and 65 bp (myb16 ± 17). Genomic DNA was derived from normal leukocytes (lanes 1 ± 4, Pr2561, Pr2581, Pr2562, and Pr2563), sporadic bovine leukosis (SBL) of T lymphomas (lanes 5 ± 9, Pr2561, Pr2530, BTL26, Pr2410, and Pr1818) and B lymphomas (lanes 10 and 11, Pr2653 and Pr2637), and enzootic bovine leukosis (EBL) (lane 12, Pr2612). PCR analysis of genomic DNA from normal (adrenal gland) and tumor tissues of a cattle Pr2410 is showed in right panel
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Northern blotting (Figure 4a ). The Pr2181 cells expressed an mRNA with 3.8 kb, while BTL ± PC3 expressed mRNAs with 4.0 kb and 3.6 kb as assessed by the C-terminal c-myb probe. The expression level of the 4.0 kb was higher than that of the 3.6 kb mRNA. When the 12-nucleotide repeat was used as a probe, only the band with 4.0 kb was detected in BTL ± PC3 cells, but not in Pr2181 cells, indicating that the c-myb gene containing the 12-nucleotide repeat was transcribed as mRNA of 4.0 kb. When the exon 9 of c-myb was used as a probe, the band with 3.6 kb was not detected, indicating that the sequence of exon 9 was deleted in the c-myb mRNA with 3.6 kb ( Figure 4a ). To examine whether the mRNA abnormalities could be detected, RT ± PCR was performed using primers myb28 and myb27 on cDNA of Pr2181 cells, BTL ± PC3 cells and tumor tissue of Pr2410 (Figure 4b) , followed by sequencing. Only a band with 317 bp was detected from Pr2181 cells by electrophoresis and ethidium bromide staining of RT ± PCR products, as has been predicted after the Northern blot analysis. On the other hand, two bands with 530 bp and 66 bp, respectively, were detected in BTL ± PC3 cells. It is notable that from Pr2410 tumor tissue two bands of 527 bp and 66 bp, respectively, were detected. Sequence analysis showed that, in the 530 bp fragment of BTL ± PC3, 17 copies of the 12-nucleotide motif and a 9-nucleotide interrupted sequence were inserted in codon 359 of the c-myb exon 9, and that in the 527 bp fragment of Pr2410 tumor tissue 16 copies of the 12-nucleotide motif and two copies of 9-nucleotide direct repeat were inserted at the same site. In these cases two nucleotides (CG) at codon 359 substituted for TT. Interestingly, the 66 bp fragment of both BTL ± PC3 cells and Pr2410 cells had the same sequences in which the exon 8 sequence was immediately followed by exon 10 sequence. Namely, the whole sequence of exon 9 (251 bp) was deleted from the 66 bp fragment.
A band of 70 kDa was detected in Pr2181 cells by immunoblotting of c-Myb (Figure 4c ), whereas two bands with 80 and 65 kDa were detected in BTL ± PC3 cells. These results suggest that two kinds of mRNAs detected by Northern blot analysis were translated into proteins; mRNA with the 12-nucleotide repeat and the 9-nucleotide interruption were thought to translate into c-Myb with in-frame insertions composed of a 4-amino acid repeat (DLPV) and three amino acids (LCG), respectively, and mRNA containing a deletion is thought to translate into c-Myb containing an internal, in-frame deletion of 85 amino acids. The expression level of the 65 kDa c-Myb was higher than that of the 80 kDa c-Myb.
Transcription-activating activity of mutant c-Myb
To test if the insertion of the 12-nucleotide repeat within exon 9 has an ability to enhance transcriptional activity, wild-type bovine c-myb, insertion mutants derived from BTL ± PC3 and Pr2410 and the deletion mutant from BTL ± PC3 ( Figure 2c Figure 5A shows that transfections with the insertion mutants (R 8 IR 9 and DR 16 D) result in low transcription-activating activity or no signi®cant dierences in comparison with wild-type c-Myb. In contrast, transfection of the deletion mutant led to three-to eightfold enhanced activity compared to wildtype c-Myb.
To assess the eects of multiplicity of the repeat on c-Myb transcription-activating activity, c-myb cDNA containing the various numbers of the repeat units were cloned under the control of the SRa promoter. Figure 5B shows that the transcription-activating activity of c-Myb decreased by inserting any number of copies of the repetitive sequences into c-myb when compared with the transcription-activating activity of the wild-type. The transcriptional activation of c-Myb was signi®cantly aected by insertion of any lengths of the repeats. The 9-nucleotide interrupting sequence and direct repeats at both ends of the 12-nucleotide repeat seemed to have no in¯uence on the interference by the 12-nucleotide repeat insertion.
Eect of the 12-nucleotide repeat on exon skipping of c-myb pre-mRNA
Since the deleted form of c-myb mRNA was detected in cells containing the 12-nucleotide repeat but not in cells without the repeat, we examined the possibility that the insertion of the 12-nucleotide repeat causes exon skipping of c-myb pre-mRNA. To investigate exon skipping of c-myb exon 9, we constructed minigenes containing c-myb exon 9 through 10 (myb14 ± 27) with or without the 12-nucleotide repeat (Figure 6a ). The cmyb exons 9 through 10 were inserted in EcoRI site downstream the 16S intron under control of SRa promoter. After transiently transfected to Cos cells, transcripts of the minigenes were ampli®ed by RT ± PCR and their sequences were determined. With the basic construct containing wild-type exon 9, an about 420 bp fragment was produced by the inclusion of 73 nucleotides of the c-myb exon 9 sequence via usage of a cryptic 5' splice site within exon 9 (Figure 6b) . Products including the whole sequence of exon 9 were not detected. Instead of them, a weak band resulting from exon skipping was detected: an about 340 bp fragment in which the ®rst exon of the SRa was spliced to exon 10. These ®ndings suggest that usage of the internal 5' splice site was the preferred pattern of exon 9 inclusion in Cos cells. As for the construct containing the 12-nucleotide repeat in exon 9, the 340 bp fragment resulting from exon skipping was more abundant than the 400 bp fragment including the 73 nucleotides of exon 9. The observed high levels of exon skipping suggest that the insertion of the 12-nucleotide repeat enhanced splicing-out of exon 9.
Discussion
In this study, we show that the insertion of the 12-nucleotide (TGATCTGCCCGT) repeat in codon 359 caused exon skipping of c-myb and that the resultant product of the deleted form of c-Myb had a three-to The minigenes used in this study were wild type exons 9 through 10 (lane 2); exons 9 through 10 containing the 12-nucleotide repeat (lane 3). Lane 1 shows product of mock transfection (pcDL-SRa vector without c-myb sequences). Products resulting from exon inclusion and skipping were indicated eightfold higher transcription-activating activity than wild-type c-Myb. Of 20 sporadic bovine T lymphomas examined for the mutation, three contained the same 12-nucleotide repeat at the same site. Although the motif of the 12-nucleotide repeat was common, its number of repeat, sequences of interruption and 9-nucleotide repeat diered among these three T lymphomas. Furthermore, the repeats were detected from tumor tissue of Pr2410 but not from adrenal gland of Pr2410. These observations suggest that insertion of the repeat occurred independently in each cattle and, at least in the case of Pr2410, it occurred in somatic cells. While the number of samples examined was small, our results suggest that the insertion of the 12-nucleotide repeat in c-myb might be involved in some cases of sporadic bovine T lymphomas. It is notable that the two T lymphomas containing the 12-nucleotide repeat (BTL ± PC3 and Pr2410) expressed the same c-myb mRNA lacking the whole sequences of exon 9 simultaneously with c-myb containing the 12-nucleotide repeat. There were no alterations in the genomic structure of c-myb, except for the exon 9 containing the repeat. The remaining T lymphoma containing the repeat (Pr1818) could not be examined because RNA from Pr2181 had not been stored. The c-myb mRNA lacking exon 9 has not been found in normal bovine hematopoietic tissues or tumors lacking the 12-nucleotide repeat. This observation implies that insertion of the repeats into codon 359 of c-myb may produce splicing errors where the splicing donor sequence of intron 8 and the splicing acceptor sequence of intron 9 are used to splice out exon 9. To elucidate if the insertion of the repeat causes exon skipping, we examined the splicing of transfected minigenes containing exon 9 with or without the 12-nucleotide repeat in Cos cells. From Cos cells transfected with a basic construct containing the complete exon 9 sequence of c-myb, a product including a part of exon 9 was detected. On the other hand, a short product resulting from exon skipping was generated from Cos cells transfected with a construct containing the 12-nucleotide repeat. These observations suggest that the insertion of the 12-nucleotide repeat in codon 359 of c-myb may cause exon 9 skipping. In murine leukemia virus-induced myeloid leukemias, insertional mutagenesis of the cmyb exon 9 has been shown to occur frequently (Weinstein et al., 1986; Mukhopadhyaya and Wol, 1992) . However, no cases of exon 9 skipping induced by insertion of virus or other foreign sequences into the c-myb gene have been reported in murine cells.
The 12-nucleotide repeat is thought to be translated into an in-frame insertion composed of a 4-amino acid repeat at codon 359 of exon 9, the boundary between the transactivation domain and the negative regulatory domain of c-Myb. To investigate the in¯uence of the insertion of the repeat on the c-Myb protein, we tested the transcription-activating activity of mutant cMyb. Both the 4-amino acid repeat and 3-amino acid insertions in codon 359 of exon 9 decreased or had no eect on the transcription-activation capacity of cMyb. These results imply that the amino acid residue 359 might not be involved in the negative regulation of c-Myb. On the other hand, c-Myb protein lacking exon 9 had three-to eightfold higher transcriptionactivating activity than the wild-type c-Myb. Since the leucine zipper was demonstrated to allow the binding of an associated inhibitory factor (Favier and Gonda, 1994) , enhanced transcriptional activity of c-Myb lacking exon 9 is thought to be a result of loss of the leucine zipper. Although c-Myb protein lacking exon 9 was more abundant than the inserted form in BTL ± PC3 cells, the expression level of the inserted form of c-myb mRNA was higher than that of the deleted form of c-myb mRNA. These observations imply that a product of the inserted form of c-myb mRNA might be more unstable than that of the deleted form.
Activation of c-myb is achieved in many murine leukemias by integration of murine leukemia virus into exon 9 with consequent truncation of the protein frequently. Integration of provirus in the NFS-60 cell line occurred in exon 9 of the c-myb locus (Weinstein et al., 1986) . The insertion introduced a terminator codon for protein synthesis at downstream of the leucine zipper. The site of integration of Friend murine leukemia virus strain FB29 locates in exon 9, 24 bp upstream of the site of integration observed in NFS-60 cells (Mukhopadhyaya and Wol, 1992) . Furthermore, v-Myb evcoded by E26 also terminated in locus corresponding to exon 9. These observations suggest that truncation of the C-terminus of c-Myb in exon 9 is capable of inducing oncogenic activation of c-Myb. On the other hand, Kanei-Ishii et al. reported that disruption of the leucine zipper structure in exon 9 markedly increased both the transactivating and transforming capacities of c-Myb (Kanei-Ishii et al., 1992). Our results indicate that removal of the exon 9 is sucient to increase transcriptional activity of c-Myb. However, it has been unclear whether the removal of the exon 9 is also sucient to induce transforming activity of c-Myb.
One intriguing question is where the 12-nucleotide repeat was derived from. DNA homology research failed to match the 12-nucleotide repeat with sequences such as retroviruses. Since it is known that there are numerous repetitive sequences in mammalian genome, we searched for the 12-nucleotide repeat in the genome. However, the 12-nucleotide repeat was not detected by Southern blot in any locus of the genome except for the c-myb gene. These results suggest that the 12-nucleotide repeat did not derive from repetitive sequences in retroviruses or the genome. It is notable that, in addition to the repeat, these mutated c-myb contained two nucleotide substitutions (CG to TT) in codon 359. This substitution produces very similar sequences to the repeat motif at both¯anking sequences of the lesion: the sequence for the 5'-half site is TGATC and for the 3'-half site is TGCCCGT (Figure 2 ). These sequences yield one motif (TGATCTGCCCGT) if they are duplicated. These ®ndings lead to the hypothesis that the 12-nucleotide repeat was newly synthesized from both the¯anking sequences of codon 359 by duplication. In the cases of chemically induced tumors in rats, tandem duplication of a 9 bp or a 12 bp sequence around codon 12 occurred in exon 1 of the K-ras gene (Higinbotham et al., 1994) . These observations provide support for our hypothesis. However, the duplicated sequences found in K-ras did not show expansion of the repeat length. Thus at least three dierent steps may be required to develop Deletion of c-myb exon 9 T Shinagawa et al the 12-nucleotide repeat in bovine c-myb, i.e. two nucleotide substitutions, tandem duplication of thē anking sequences and their expansion. Further work is clearly necessary to elucidate the mechanism of the insertion of the 12-nucleotide repeat.
Materials and methods
Cells and cell cultures
Bovine T lymphoma cell lines, Pr2181, BTL ± PC3 and its clones (BTL26, BTL32 and BTL39) , and the human B lymphoma cell line Raji (provided by S Imajo-Ohmi, the University of Tokyo) were cultured in Dulbecco's modi®ed Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum, 100 U of penicillin per ml, and 100 mg of streptomycin per ml. Cos cells and NIH3T3 cells were maintained in the same medium supplemented with 5% heat-inactivated fetal bovine serum and antibiotics.
Bovine tumor tissues and tumor cell lines were derived from cattle suering from sporadic bovine leukosis (20 samples of T lymphoma and 12 samples of B lymphoma), enzootic bovine leukosis (®ve samples), kidney carcinoma (two samples), and adenoma (one sample). Leukocytes from cattle without tumors were used as controls (28 samples).
Southern and Northern blot analysis
Cellular DNA was prepared as described by . Ten micrograms of the DNA were digested with restriction enzymes (Boehringer Mannheim GmbH; Mannheim, Germany). The DNA samples were separated by electrophoresis through 1.2% agarose gels in 16TBE buer, transferred to Hybond-N nylon membrane (Amersham Life Science, Buckinghamshire, UK), and hybridized in a solution containing 66standard sodium citrate (SSC) and 0.1% SDS at 658C for 20 h, with oligomer-primed 32 Plabeled probes. After hybridization, the ®lters were washed with 26SSC and 0.1% SDS for 30 min at 658C.
RNA blots were performed according to the method of Sambrook et al. (1989) . RNA was extracted with guanidinium/cesium chloride from bovine T lymphoma cells. Total RNA (10 mg) was denatured with glyoxal, electrophoresed, transferred to a nylon membrane and hybridized with 32 Plabeled probes. After washing, the ®lters were exposed to autoradiography. To remove the probe, the ®lter was boiled in water, then rehybridized with another probe.
Genomic DNA cloning procedures
Genomic DNA was digested with EcoRI, and fragments around 3.5 kb were isolated by electroelution from 0.7% agarose gels. The fragments were ligated to lZAPII arms and in vitro packaged into l bacteriophage (Gigapack Gold; Strategene, Lajolla, CA). The genomic DNA library was screened with bovine c-myb cDNA probe (a 251 bp fragment, 958 ± 1208). The sequence of the bovine c-myb cDNA can be obtained from GenBank [accession number D26147 ]. The cloned fragments were sequenced by the dideoxy method on an Applied Biosystems Model 373A sequencer. Intron 9 sequence was ampli®ed by LA ± PCR using a primer set myb14 (5'-CAGAACCACACATGCAGCTA-3', 958 ± 977) and myb27 (5'-CATTTCCAAGTCTAAGTTTTCA-3', 1254 ± 1233) according to the protocol of the manufacturer (Takara Shuzo Co, Ltd, Shiga, Japan). The fragments were cloned into the EcoRI site of plasmid vector pcDL-SRa (Takebe et al., 1988) and sequenced. The resulting constructs were also used for experiment of exon skipping.
Genomic PCR and RT ± PCR analysis
Reverse transcription was performed with oligo(dT) 12 ± 18 primer using 1 mg of total RNA. RT ± PCR was performed with one tenth of the reaction. Fifty microliter PCR reactions contained either the cDNA or 1 ng genomic DNA, 10 mM Tris-Cl (pH 9.0), 1.5 mM MgCl 2 , 50 mM KCl, 0.1% Triton X-100, 20 pmol each of primers, 50 mM deoxynucleoside triphosphates, and 1 U of Taq DNA polymerase (Promega, Madison, WI). Primers used for PCR were myb16 (5'-AAGAGCACCACTCCACTCCA-3', 1052 ± 1071), myb17 (5'-AGAGGCACTTTCTTCAGG-TAG-3', 1116 ± 1096), and myb20 (5'-ATCTTTCCTCTAA-CAGCATC-3', intron 8), myb27, and myb28 (5'-GAACGAACTCAAAGGACAGC-3', 924 ± 943). The templates were denatured at 968C for 5 min, and ampli®ed for 25 rounds at 968C for 40 s, 548C for 30 s, and 748C for 1.5 min. Aliquots of the reaction were analysed by electrophoresis on 1.5% agarose gels.
Immunoblotting
A total of 10 6 cells was centrifuged and resuspended in sodium dodecyl sulfate (SDS) loading buer. After loading, samples were electrophoresed on an SDS ± 10% polyacrylamide gel and transferred to a PVDF membrane (Amersham). An anti-mouse c-Myb type I monoclonal antibody (Upstate Biotechnology, Inc., Lake Placid, NY) that crossreacts with bovine c-Myb was incubated 48C overnight at 0.4 mg/ml. The secondary antibody was an anti-mouse horseradish peroxidase conjugate. Bound antibody complexes were visualized with an enhanced chemiluminescence system (Amersham).
Plasmid constructions
Plasmid DNA manipulations and preparations were performed by standard methods. All constructs were checked by restriction mapping, and in-frame fusions and products of the PCR were veri®ed by double-stranded sequencing using standard techniques.
Bovine c-myb cDNA with full length coding sequences (2.1 kb, Pr2181 cells), insertion mutations (2.3 kb, BTL39 cells and Pr2410 tumor tissue) and a deletion mutation (1.8 kb, BTL39 cells) were synthesized by RT ± PCR. The forward fragment of c-myb was ampli®ed from Pr2181 cells using primers mybB1 (5'-CGCGCCATGGCCCGAAGACC-3', 1 ± 20) and myb15 (5'-ACAATCTATAAATTGAAGTGT-3', 1208 ± 1189) and cloned into the SmaI site in plasmid vector pKS+, yielding pKS+Pr2181 B1 ± 15. The backward fragments of wild-type c-myb were ampli®ed from Pr2181 cells using primers myb1 (5'TTAGAGTTGCTTC-TAATGTC-3', 898 ± 917) and myb13 (5'-CCTAAATG-CACTTGGTGCTG-3', 2077 ± 2058) and cloned into the SmaI site in pKS+ to give pKS+Pr2181 1 ± 15. A SmaIXhoI fragment of pKS+Pr1281 B1 ± 15 containing the vector and the forward c-myb cDNA was ligated with a SmaI ± XhoI fragment of pKS+Pr2181 1 ± 13 containing the backward cmyb, yielding pKS+WT. Alternatively, backward fragments of c-myb cDNA containing insertion or deletion mutations were ampli®ed from BTL39 cells and Pr2410 tumor tissue using primer sets myb14 and myb13, or myb1 and myb13 and cloned into HincII site in pKS+, yielding pKS+BTLins 14 ± 13, pKS+BTLdel 1 ± 13, and pKS+Pr2410ins 1 ± 13, respectively. The SmaI fragments of pKS+BTLins 14 ± 13 and pKS+BTLdel 1 ± 13 were inserted into the SmaI site of pKS+Pr2181 B1 ± 15 to give pKS+R 8 IR 9 and pKS+Del, respectively. A SmaI-XhoI fragment of pKS+Pr2410 1 ± 13 was ligated with the SmaI-XhoI fragment of pKS+Pr2181 B1 ± 15, yielding pKS+DR 16 D. Plasmids for expression of cmyb cDNA were prepared by inserting the NotI-EcoRV or NotI-XhoI fragments with bovine c-myb cDNA into the EcoRI site of pcDL-SRa or the HindIII site of pRSV2 ; both vectors and inserts were treated with Klenow enzyme before ligation.
To construct various lengths of insertion mutations in the c-myb cDNA, repetitive sequences were ampli®ed by PCR using primers myb14 and myb17 from pKS+R 8 IR 9 . The ampli®ed DNA was completely digested with SmaI and was by partially digested with MboI to give the cohesive end of 5'-GATC. The DNA fragments were subcloned into SmaIBamHI-digested pKS+WT which had 5'-GATC single strand DNA. The plasmids with various lengths of repetitive sequences were digested with NotI and EcoRV, treated with Klenow enyzme, and were subcloned into the EcoRI site of pcDL-SRa. All constructs cloned by PCR were veri®ed by sequencing.
CAT assay
Cos cells and NIH3T3 cells were cotransfected with activator plasmids (2 mg) and the reporter plasmid EW5(7)CAT (5 mg) (Chen and Lipsick, 1993) by the calcium phosphate precipitation method (Sambrook et al., 1989) . Cytomegalovirus-b-galactosidase (0.5 mg) was used as an internal control for transfection eciency. Cells were harvested 48 to 60 h later for assay of CAT activity, performed as described by Sambrook et al. (1989) . The Raji cells were electroporated essentially by the procedure of Ess et al. (1995) . Brie¯y, for each transfection, 10 7 cells in exponential growth were washed with PBS and were resuspended in 0.3 ml of PBS. The cells were added to 0.4 cm Invitrogen cuvettes containing transfection DNA, brie¯y mixed, and were electroporated at 260 V and 1000 mF in the Electroporator II (Invitrogen, San Diego, CA). The cells were left on ice for 5 min, plated in the culture medium, and they were harvested 45 to 48 h later for assay of CAT activity.
Analysis of exon skipping
Cos cells were transfected with 5 mg of expression vector pcDL-SRa containing exons and intron sequences of c-myb (myb14 ± 27) at EcoRI site by the calcium phosphate precipitation method. Cells were harvested 48 h later and RNA was extracted. cDNA was synthesized with oligo(dT) 12 ± 18 primer from the total RNA and RT ± PCR was performed using a primer set, SR (5'-TGTTTCGTTTTCTGTTCTGC-3', SRa promoter) and myb27.
